EGFR monoclonal antibody panitumumab inhibits chronic proliferative cholangitis by downregulating EGFR

In hepatolithiasis, chronic proliferative cholangitis (CPC), an active and longstanding inflammation of stone-containing bile ducts with enhanced mucin-producing activity, not only affects the progression of the disease, it can also induce biliary carcinogenesis. The present study aimed to examine t...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, San-Hu, Chen, Xue-Fang, Xie, Zhi-Bin, Zhou, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559293/
https://www.ncbi.nlm.nih.gov/pubmed/31115490
http://dx.doi.org/10.3892/ijmm.2019.4190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559293/
https://www.ncbi.nlm.nih.gov/pubmed/31115490
http://dx.doi.org/10.3892/ijmm.2019.4190

Ejemplares similares